Gsa Capital Partners LLP Marker Therapeutics, Inc. Transaction History

Gsa Capital Partners LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$1.47 - $3.29 $218,480 - $488,979	-148,626 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$1.36 - $1.75 $82,579 - $106,260	60,720 Added 69.07%	148,626 $216,000
Q3 2020 Nov 06, 2020	BUY	$1.5 - $2.2 $104,184 - $152,803	69,456 Added 376.46%	87,906 $132,000
Q2 2020 Aug 11, 2020	SELL	$1.69 - $2.79 $152,520 - $251,794	-90,249 Reduced 83.03%	18,450 $38,000
Q1 2020 May 12, 2020	SELL	$1.59 - $3.35 $93,126 - $196,209	-58,570 Reduced 35.02%	108,699 $207,000
Q4 2019 Feb 12, 2020	BUY	$2.68 - $4.85 $448,280 - $811,254	167,269 New	167,269 $482,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $236M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.